Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check3 days agoChange DetectedEnrollment status on the page now shows 'No longer looking for participants', indicating that recruitment has closed. The page also adds new help/guide sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with the revision tag to v3.6.0.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page footer now shows Revision: v3.5.5, indicating a newer version of the study record. This update does not alter the study details or eligibility criteria.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows a new revision label: v3.5.4, replacing the previous v3.5.3 in the document revision list. This indicates an updated version of the study-related documents has been published.SummaryDifference0.0%

- Check39 days agoChange DetectedLocation list updated: Taoyuan District, Taiwan, 333 was replaced with Taoyuan, Taiwan, 333, and a new Taoyuan, Taiwan site (333) was added.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page shows a new revision tag of v3.5.3 replacing the previous v3.5.2, signaling a newer release of the page. This typically reflects minor release updates rather than substantive changes to the study data.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.